Effects of tamoxifen on Doppler velocimetry parameters of periurethral vessels in postmenopausal women

International Urogynecology Journal

Volumn 16, Issue 1, 2005, Pages 56-59

  Faria, Carlos A ^a   Sartori, Marair G ^a   Baracat, Edmund C ^a   Rodrigues de Lima, Geraldo ^a   Girão, Manoel J B C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Doppler; Periurethral vessels; Tamoxifen

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; BLOOD VESSEL; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DOPPLER FLOWMETRY; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE FLOW; URETHRA; VASCULAR RESISTANCE;

EID: 12144272032     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-004-1212-2     Document Type: Article

References (25)

1. Klutke JJ, Bergman A (1995) Hormonal influence on the urinary tract. Urol Clin North Am 22:629-639
2. Sartori MGF, Baracat EC, Girào MJBC, et al. (1995) Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens. Int J Gynaecol Obstet 49:165-169 10.1016/0020-7292(95)02358-J
3. Greene JL, Gilna P, Waterfield M, Baker A, et al. (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150-1154 1:CAS:528:DyaL28XhvVSqs70%3D
4. Kuiper GGJM, Enmark E, Pelto-Huikko M, et al. (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93:5925-5930
5. Mosselman S, Polman J, Dijkema R (1996) ER β: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53 10.1016/0014-5793(96)00782-X
6. Ogawa S, Inoue S, Watanabe T, et al. (1998) The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ER z in vivo and in vitro. Biochem Biophys Res Commun 243:122-126
7. Iosif CS, Batra S, Ek A, et al. (1981) Estrogen receptor in the human female lower urinary tract. Am J Obstet Gynecol 141:817-820 1:STN:280:Bi2D1cfnt1M%3D
8. Suguita M, Girào MJBC, Simòes MJA, et al. (2000) A morphologic and morphometric study of the vesical mucosa and urethra of castrated female rats following estrogen and/or progestogen replacement. Clin Exp Obstet Gynecol 27:176-178 1:STN:280:DC%2BD3M3gtlKisw%3D%3D
9. Endo RM, Girào MJBC, Sartori MGF, et al. (2000) Effect of estrogen-progestogen hormonal replacement therapy on periurethral and bladder vessels. Int Urogynecol J 11:120-123 10.1007/s001920050081
10. Raz S, Caine M, Zeigler M (1972) The vascular component in the production of intraurethral pressure. J Urol 108:93-96 1:STN:280:CS2B3cjjtVY%3D
11. Rud T, Andersson KE, Asmussen M, et al. (1980) Factors maintaining the intraurethral pressure in women. Invest Urol (Berl) 17:343-347
12. Gosling RG, Dumbar G, King DH, et al. (1971) The quantitative analysis of occlusive peripheral arterial disease by a non-intrusive ultrasonic technique. Angiology 22:52-55 1:STN:280:CS6C3M%2Fis1A%3D
13. Pourcelot L (1975) Indications de l'ultrasonographie doppler dans l'etude des vaisseaux périphériques Rev Prat 25:4671-4680
14. Stuart B, Drumm J, Fitzgerald DE, et al. (1980) Fetal blood velocity waveforms in normal pregnancy. Br J Obstet Gynecol 87:780-785 1:STN:280:Bi6D3sbos1A%3D
15. Jármy-Di Bella ZIK, Girào MJBC, Sartori MGF, et al. (2000) Power Doppler of the urethra in continent or incontinent, pre and postmenopausal women. Int Urogynecol J 11:148-155
16. Girào MJBC, Jármy-Di Bella ZIK, Sartori MGF, et al. (2001) Dopplervelocimetry parameters of periurethral vessels in postmenopausal incontinent women receiving estrogen replacement. Int Urogynecol J 12:241-246
17. Goldstein SR (1998) Selective estrogen receptor modulators: A new category of therapeutic agents for extending the health of postmenopausal women. Am J Obstet Gynecol 179:1479-1484 1:CAS:528:DyaK1MXksl2iug%3D%3D
18. Jordan VC (1997) Tamoxifen: The herald of a new era of preventive therapeutics. J Natl Cancer Inst 89:747-749 10.1093/jnci/89.11.747
19. Iosif CS, al-Hijji J, Samsioe G (2002) Effects of tamoxifen and estradiol on estrogen binding sites in the urogenital tract: An experimental study in the rabbit. Gynecol Endocrinol 16:379-383 1:CAS:528:DC%2BD38Xps1ymt74%3D
20. Vardy M, Lindsay R, Scotti R, et al. (2003) Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 189:81-88 10.1067/mob.2003.374
21. Iguchi T, Hirokawa M, Takasugi N (1986) Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonattaly to tamoxifen. Toxicology 42:1-11 10.1016/0300-483X(86)90087-9
22. Fisher B, Constantini JP, Redmond CK, et al. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537 10.1093/jnci/86.7.527
23. Fraiser LH, Kanekal S, Kehrer, JP (1991) Cyclophosphamide toxicity - characterising and avoiding the problem. Drugs 42:781-795 1:STN:280:By2C3sjgs10%3D
24. Marks LB, Carrol PR, Dugen TC, et al. (1995) The response of the urinary bladder, urethra and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31:1257-1280 10.1016/0360-3016(94)00431-J
25. Caetano JPL, Faria MML, Lins RM, et al. (1996) Princípios básicos e aplicaçóes da dopplervelocimetria em ginecologia e obstetrícia J Bras Ginecol 106:233-242